` FSNUY (Fresenius SE & Co KGaA) vs S&P 500 Comparison - Alpha Spread

FSNUY
vs
S&P 500

Over the past 12 months, FSNUY has significantly outperformed S&P 500, delivering a return of +43% compared to the S&P 500's +17% growth.

Stocks Performance
FSNUY vs S&P 500

Loading
FSNUY
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
FSNUY vs S&P 500

Loading
FSNUY
S&P 500
Difference
www.alphaspread.com

Performance By Year
FSNUY vs S&P 500

Loading
FSNUY
S&P 500
Add Stock

Competitors Performance
Fresenius SE & Co KGaA vs Peers

Fresenius SE & Co KGaA
Glance View

Fresenius SE & Co. KGaA, a titan in the global healthcare sector, traces its origins to a humble pharmacy in Frankfurt, Germany, in 1912. Since then, the company has evolved into a multifaceted healthcare conglomerate, positioning itself prominently in four main divisions: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. Each segment synergizes to form a comprehensive healthcare ecosystem. Fresenius Medical Care, the crown jewel of the group, stands as the world’s leading provider of products and services for individuals with renal diseases. This division, with a focus on dialyzing patients suffering from chronic kidney failure, operates a vast network of dialysis clinics and manufactures dialysis machines and related products that account for a significant portion of its income. Meanwhile, Fresenius Kabi, the pharmaceutical and medical device division, specializes in lifesaving drugs and technologies for critically and chronically ill patients. This division thrives on providing clinical nutrition, infusion therapy, and generics, positioning itself as a critical player in hospitals worldwide. Fresenius Helios is acknowledged as Europe's largest private hospital operator, managing a vast array of healthcare facilities that deliver inpatient and outpatient care, ensuring a steady stream of revenue through diverse healthcare services. Lastly, Fresenius Vamed provides a wide range of services for healthcare facilities, from project development and construction to full operational management, allowing the company to gain financial benefits from turnkey hospital solutions and infrastructure development. Through these concerted efforts, Fresenius SE & Co. KGaA cements its role as a key stakeholder in the global healthcare market, generating substantial revenues while addressing diverse medical needs across the globe.

FSNUY Intrinsic Value
19 USD
Undervaluation 35%
Intrinsic Value
Price
Back to Top